Bio Spec

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Overview

Bio Spec Overview

Ignite Creation Date: 2025-12-24 @ 11:56 PM
Last Modification Date: 2025-12-24 @ 11:56 PM
Retention: SAMPLES_WITH_DNA
Description: At least one whole blood and saliva drawn a) in the emergency department (if available) or hospital within 8 days of the onset of symptoms; and if they agree, a further two samples at b) 24 hours +/- 6 hours from symptom onset (if available); and c) 48 hours +/- 6 hours from symptom onset (if available).

Liquid biopsy for retention:

• Whole Blood samples, red blood cell effluent, plasma, white cell pellet(for genomic, epigenomic, transcriptomic and proteomic studies). serum (for proteomic, metabolomic and lipidomic studies), salivary supernatant, salivary cells. Biomarkers under investigation: DNA gene expression, RNA gene expression, Proteomics expression, Metabolomics expression and Lipidomics expression in peripheral blood and saliva
Section: At least one whole blood and saliva drawn a) in the emergency department (if available) or hospital within 8 days of the onset of symptoms; and if they agree, a further two samples at b) 24 hours +/- 6 hours from symptom onset (if available); and c) 48 hours +/- 6 hours from symptom onset (if available). Liquid biopsy for retention: • Whole Blood samples, red blood cell effluent, plasma, white cell pellet(for genomic, epigenomic, transcriptomic and proteomic studies). serum (for proteomic, metabolomic and lipidomic studies), salivary supernatant, salivary cells. Biomarkers under investigation: DNA gene expression, RNA gene expression, Proteomics expression, Metabolomics expression and Lipidomics expression in peripheral blood and saliva